Pacific Edge Limited (PFGTF)
USD 0.08
(-28.57%)
USD 0.08
(-28.57%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 65.44 Million NZD | -32.61% |
| 2023 | 56.88 Million NZD | -28.82% |
| 2022 | 79.91 Million NZD | 265.91% |
| 2021 | 21.83 Million NZD | 90.6% |
| 2020 | 11.45 Million NZD | -30.83% |
| 2019 | 16.56 Million USD | -15.76% |
| 2018 | 19.66 Million USD | 11.06% |
| 2017 | 17.7 Million USD | -21.12% |
| 2016 | 22.44 Million USD | 137.11% |
| 2015 | 9.46 Million NZD | -52.01% |
| 2014 | 19.72 Million NZD | 92.96% |
| 2013 | 10.22 Million NZD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 41.36 Million USD | -14.17% |
| 2024 Q4 | 71.34 Million USD | 0.0% |
| 2024 Q1 | 46.8 Million USD | -16.12% |
| 2024 FY | 65.44 Million NZD | 15.05% |
| 2024 Q2 | 45.7 Million USD | 0.0% |
| 2023 Q3 | 57.72 Million USD | -3.33% |
| 2023 FY | 56.88 Million NZD | -28.82% |
| 2023 Q4 | 56.88 Million NZD | -1.46% |
| 2023 Q2 | 59.72 Million USD | 0.0% |
| 2022 FY | 79.91 Million NZD | 265.91% |
| 2022 Q2 | 68.96 Million USD | 0.0% |
| 2022 Q4 | 79.91 Million USD | 0.0% |
| 2021 Q4 | 21.83 Million USD | 0.0% |
| 2021 FY | 21.83 Million NZD | 90.6% |
| 2021 Q2 | 24.44 Million USD | 0.0% |
| 2020 Q4 | 11.45 Million USD | 0.0% |
| 2020 FY | 11.45 Million NZD | -30.83% |
| 2020 Q2 | 6.15 Million USD | 0.0% |
| 2019 FY | 16.56 Million USD | -15.76% |
| 2018 FY | 19.66 Million USD | 11.06% |
| 2017 FY | 17.7 Million USD | -21.12% |
| 2016 FY | 22.44 Million USD | 137.11% |
| 2015 FY | 9.46 Million NZD | -52.01% |
| 2014 FY | 19.72 Million NZD | 92.96% |
| 2013 FY | 10.22 Million NZD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -5057.447% |
| Arrayit Corporation | 1 Million USD | -6442.255% |
| Atlantic International Corp. | 4.43 Million USD | -1375.263% |
| Biocept, Inc. | 30.87 Million USD | -111.991% |
| Bioqual, Inc. | 56.58 Million USD | -15.657% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -28118.615% |
| DermTech, Inc. | 121.93 Million USD | 46.323% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 98.436% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | -268.148% |
| iMD Companies, Inc. | 190.13 Thousand USD | -34321.496% |
| IDenta Corp. | 1.52 Million USD | -4179.675% |
| Interpace Biosciences, Inc. | 13.02 Million USD | -402.634% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -693.125% |
| InVitro International | 1.53 Million USD | -4166.473% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | -143.863% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -2830695.804% |
| Medical Imaging Corp. | 4.19 Million USD | -1461.398% |
| NovelStem International Corp. | 2.25 Million USD | -2802.935% |
| Optigenex Inc. | 1.88 Million USD | -3365.993% |
| PharmChem, Inc. | 2.76 Million USD | -2266.538% |
| Proteome Sciences plc | 14.58 Million USD | -348.703% |
| Response Genetics, Inc | 48.88 Million USD | -33.884% |
| Rennova Health, Inc. | 20.57 Million USD | -218.129% |
| RushNet, Inc. | 6.04 Million USD | -982.214% |
| ScreenPro Security Inc. | 1.26 Million USD | -5088.689% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -13753.686% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -9241.014% |
| Todos Medical Ltd. | 15.26 Million USD | -328.689% |